Home/Pipeline/Edol Portfolio

Edol Portfolio

Various Ophthalmology Conditions

MarketedIntegration (Acquired)

Key Facts

Indication
Various Ophthalmology Conditions
Phase
Marketed
Status
Integration (Acquired)
Company

About Faes Farma

Faes Farma is a leading Spanish pharmaceutical group with a mission to transform health through passion, science, and innovation, achieving €627 million in revenue in 2025 with 23% year-over-year growth. Its strategy is built on a vertically integrated model, a focus on key therapeutic molecules like Bilastine and Calcifediol, and strategic acquisitions to bolster international presence and leadership in ophthalmology. The company aims to be at the forefront of excellence in health and well-being, supported by a dual business model spanning human pharmaceuticals and animal nutrition.

View full company profile

Other Various Ophthalmology Conditions Drugs

DrugCompanyPhase
SIFI PortfolioFaes FarmaMarketed